Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.461, 2004-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Latest guidance issued by UK NICE
Inpharma, Vol. 1, Iss. 1453, 2004-01 ,pp. :
Insufficient evidence behind latest UK NICE guidance
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 480, 2005-01 ,pp. :
Guidance on somatropin use in GH deficiency issued by UK NICE
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 365, 2002-01 ,pp. :
Doxorubicin liposomal in ovarian cancer guidance issued by UK NICE
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 374, 2002-01 ,pp. :
Anti-D-Rh0 immunoglobulin guidance issued by UK NICE
Inpharma, Vol. 1, Iss. 1339, 2002-01 ,pp. :